Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -8 of 8 Show results per page	View Search Criteria \| Help With Results

Last Modified: 10/16/2007 First Published: 8/24/2003


1.		Phase II Study of Lycopene in Patients With Asymptomatic Androgen-Independent Metastatic Prostate Cancer Who Have an Elevated Prostate-Specific Antigen Level

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				NCCTG-N0351 N0351, NCT00068731

Last Modified: 12/16/2004 First Published: 8/1/2000


2.		Phase I Study of Lycopene for the Chemoprevention of Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Prevention				Completed				18 to 45				NCI				UIC-H-99-058 UIC-N01-CN-85081, NCI-P00-0143, NCT00006078

Last Modified: 11/2/2006 First Published: 9/25/2004


3.		Phase I Study of Lycopene as Chemoprevention for Prostate Cancer in Healthy Participants

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Prevention				Completed				18 to 45				NCI				UIC-2004-0040 N01-CN-85081-3, NCT00093561

Last Modified: 7/20/2006 First Published: 4/21/2006


4.		Phase I Chemoprevention Study of Lycopene in Patients at High Risk of Developing Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Prevention				Completed				35 to 75				NCI				UIC-2000-0931 NCT00416325

Last Modified: 12/20/2007 First Published: 3/16/2007


5.		Phase I Randomized Study of Lycopene in Healthy Male Participants

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Prevention				Closed				18 to 55				NCI				UIC-2006-0853 N01-CN85081-4, NCT00450957

Last Modified: 10/15/2007 First Published: 8/1/2002


6.		Randomized Pilot Study of Isoflavones Versus Lycopene Prior to Radical Prostatectomy in Patients With Localized Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Biomarker/Laboratory analysis, Treatment				Completed				45 to 80				NCI				MCC-0105 NCI-3811, NCI-P02-0216, HLMCC 0105, NCT00042731

Last Modified: 10/15/2007 First Published: 8/13/2006


7.		Randomized Study of Lycopene in Patients With Prostate Cancer or Benign Prostatic Hyperplasia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Biomarker/Laboratory analysis, Prevention, Treatment				Closed				Not specified				NCI				UIC-1999-0489 NCT00416390

Last Modified: 6/14/2008 First Published: 11/13/2006


8.		Randomized Study of the Molecular Effects of Lycopene Versus Omega-3 Fatty Acid Nutritional Supplements in Patients With Stage I or II Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Biomarker/Laboratory analysis, Treatment				Closed				Not specified				NCI				UCSF-03553 UCSF-H5664-22834-04A, NCT00402285

Select All on One Page